Overview of Optima NIPT Plus+

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It is associated with varying degrees of intellectual disability and may include characteristic physical features. Individuals with Down syndrome may also have associated medical conditions, such as congenital heart defects or thyroid disorders, which can require ongoing medical care. With advances in medical management, early intervention, and supportive therapies, many individuals lead active and fulfilling lives. While some pregnancies with Down syndrome may result in miscarriage, it remains one of the most commonly occurring chromosomal conditions identified in prenatal screening.

Edwards syndrome is caused by an extra copy of chromosome 18 and is associated with severe developmental and medical complications. Affected pregnancies have a high likelihood of miscarriage or stillbirth. Babies born with this condition often have significant health challenges, including heart defects, growth restriction, and organ abnormalities. Survival beyond the first year of life is uncommon, and those who do survive typically require intensive medical support.

Patau syndrome results from an extra copy of chromosome 13 and is associated with severe intellectual and physical abnormalities. Common findings include brain and heart defects, cleft lip or palate, and other organ malformations. Many affected pregnancies result in miscarriage or stillbirth. Infants born with trisomy 13 often have a limited life expectancy and require specialized medical care.

Turner syndrome (Monosomy X) affects females and may be associated with short stature, infertility, and certain medical conditions such as heart or kidney abnormalities.

Triple X (XXX) is often associated with mild or no physical symptoms, though some individuals may experience learning or developmental differences.

Klinefelter syndrome (XXY) affects males and may be associated with reduced fertility, learning difficulties, and hormonal differences.

Jacobs syndrome (XYY) is often associated with mild or no physical symptoms, though some individuals may experience learning or developmental differences.

XXYY syndrome is a rare sex chromosome condition that occurs in males when there are two extra chromosomes (XXYY instead of XY). It is associated with developmental differences, including speech and learning difficulties, as well as behavioral and social challenges. Some individuals may also have medical features such as low testosterone levels, which can affect puberty and fertility. The severity and combination of features can vary between individuals. With appropriate medical care, educational support, and early intervention, many individuals with XXYY syndrome can make meaningful developmental progress and lead fulfilling lives.

This condition is caused by a small missing segment of chromosome 22 and can affect multiple systems in the body. It is commonly associated with heart defects, immune system differences, and developmental delays. The severity can vary significantly between individuals. Early diagnosis allows for appropriate medical management and developmental support.

1p36 deletion syndrome is caused by a missing segment at the end of chromosome 1. It is associated with developmental delay, intellectual disability, and, in some cases, seizures or heart conditions. The clinical presentation can vary, and early intervention can help improve developmental outcomes.

This condition is caused by a deletion on chromosome 4 and is associated with growth restriction, developmental delay, and characteristic facial features. Medical complications can include seizures and congenital anomalies. The severity varies, and care typically involves multidisciplinary support.

Smith–Magenis syndrome is a developmental condition caused by a deletion on chromosome 17. It is associated with intellectual disability, behavioral differences, and sleep disturbances. Early diagnosis allows for better management of symptoms and supportive care.

Cri-du-chat syndrome is caused by a deletion on chromosome 5. It is named after the characteristic cry observed in some affected infants. The condition is associated with developmental delay, intellectual disability, and distinct facial features. Supportive care and early intervention can improve quality of life.

Prader–Willi syndrome is a genetic condition affecting appetite regulation, growth, and development. Infants may have low muscle tone and feeding difficulties, while later in life, individuals may develop increased appetite and require careful management to prevent obesity. With appropriate care and monitoring, individuals can benefit from structured support and therapies.

Angelman syndrome is a neurological condition characterized by developmental delay, speech impairment, and movement or balance difficulties. Individuals often have a happy demeanor and may experience seizures. Early diagnosis and supportive therapies can significantly improve quality of life.

Cystic fibrosis is an inherited genetic condition that affects the lungs and digestive system. It is caused by changes in a gene that regulates salt and fluid balance in the body, leading to the production of thick, sticky mucus. This can result in chronic lung infections, breathing difficulties, and problems with nutrient absorption. The severity of cystic fibrosis can vary, but it typically requires lifelong medical care. Advances in treatment have significantly improved quality of life and life expectancy, allowing many individuals to live into adulthood with appropriate management.

Beta-thalassemia is an inherited blood disorder that affects the body’s ability to produce hemoglobin, the protein in red blood cells that carries oxygen. This can lead to anemia, fatigue, and other complications. The condition ranges from mild to severe. In more severe cases, individuals may require regular blood transfusions and ongoing medical care. With appropriate treatment and monitoring, many individuals can manage the condition and maintain a good quality of life.

Tay-Sachs disease is a rare inherited neurological condition caused by the absence of an enzyme needed to break down certain fatty substances in the brain. As a result, these substances accumulate and lead to progressive damage to the nervous system. The most severe form presents in early infancy and is associated with developmental regression, loss of motor skills, and reduced life expectancy. Although there is currently no cure, early identification is important for family planning and supportive care.

These conditions may occur even in families with no known history.